Preventive Sexual Health Screening Among Female-to-Male (FTM) Transgender Adult Patients

Completed

Conditions studied: Uterine Cervical Neoplasms, Sexually Transmitted Diseases

In brief

The purpose of this study is to assess the acceptability and effectiveness of utilizing vaginal self-swabs for HPV DNA testing as compared to provider-collected cervical swabs for HPV, as well as to investigate the prevalence of other Sexually Transmitted Infections (STIs) among sexually active female-to-male (FTM) transgender adults.

Key facts

Study ID

NCT02401867

Run by

Fenway Community Health

People needed

150

Starts

2015-01-01

Expected to finish

2016-09-01

Last updated by the study team

2017-06-28

Who can join

Age: 21 and older, up to 64. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Age 21-64
• Assigned a female sex at birth and now self-identifies as a man, trans masculine, trans man, FTM, transgender, genderqueer/non-binary, transsexual, male, and/or another diverse transgender identity or expression
• Have a cervix
• Sexually active in the past 36 months (with sexual partner(s) of any gender)
• Able to speak and understand English
• Willing and able to provide informed consent

You may not qualify if…

• Unable to provide informed consent due to severe mental or physical illness
• Substance intoxication at the time of interview

Where it is running

• Fenway Community Health — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.